Nrc Health (NRC) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nrc Health  (NASDAQ: NRC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Nrc Health's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Nrc Health's ROA in the second quarter of 2026?
Nrc Health achieved a return on average assets (ROA) of 4.32 % in its second quarter of 2026, which is below Nrc Health's average return on assets, which stands at 19.95%.

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 166 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 850 to 943.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -3.37 % -0.38 % 1.9 % 2.34 % 18.3 %
Y / Y Net Income Change - -44.32 % -72.61 % -27.53 % -
Net Income (TTM) in million 6 9 12 16 18
Return On Assets (TTM) 4.32 % 6.63 % 8.5 % 12.05 % 13.28 %
NRC's Total Ranking # 943 # 850 # 490 # 416 # 260
Total Assets (TTM) in million 136 135 135 135 141
Seq. Total Assets Change 1.18 % -0.24 % 0 % -4.27 % 4.31 %
Seq. Net Income Change - 79.3 % -56.4 % - -

NRC's 5 Years Annual ROA >> Back to NRC Management Effectiveness >> Compare NRC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 11
Sector # 167
Overall # 1293

Return On Assets Statistics
High Average Low
32.81 %
19.95 %
4.31 %
(Mar 31 2020)   (Jun 30 2026)





Financial Statements
Nrc Health's Assets $ 136 million NRC's Balance sheet
Nrc Health's Income $ -3 million Quarterly NRC's Income Statement
NRC's Income by Division See NRC's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 1.9 % 8.11 % -5.95 % -16.81 % 19.92 %
Total Assets in million 135 132 122 130 157
Y / Y Net Income Change -53.19 % -19.98 % -2.61 % -15.12 % 0.55 %
Net Income in million 12 25 31 32 37
Annual Return On Assets 8.6 % 18.72 % 25.3 % 24.43 % 23.94 %

NRC's 5 Years Annual ROA >> Back to NRC Management Effectiveness >> Compare NRC ROA to its Competitors



Comment on NRC's ROA in the fiscal year ending 2025
In the fiscal year 2025 Nrc Health's ROA decreased compared to previous year to 8.6 %, due to deterioration of net income -53.19 % to $11.60 million, from $24.78 million a year ago, as NRC's assets were $134.88 million.


More Return On Assets Ratios
NRC's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NRC's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NRC's Competitors
Subscribers only: Roa for Nrc Health's Suppliers
Subscribers only: Return On Assets for NRC's Customers

You may also want to know
NRC's Roi NRC's Inventory Turnover Ratio NRC's Growth Rates NRC's Dividend Comparisons
NRC's Profitability Ratios NRC's Asset Turnover Ratio NRC's Dividend Growth
NRC's Roe NRC's Valuation Ratios NRC's Financial Strength Ratios NRC's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Ligand Pharmaceuticals Incorporated  11.68 %
Theravance Biopharma inc   11.68 %
Carlisle Companies Incorporated  11.62 %
Encompass Health Corporation  11.60 %
Protagonist Therapeutics inc   11.02 %
Agilent Technologies inc   10.97 %
Prestige Consumer Healthcare Inc   10.90 %
Lemaitre Vascular Inc   10.90 %
Ufp Technologies Inc   10.85 %
Progyny Inc   10.66 %
Regeneron Pharmaceuticals Inc   10.60 %
Johnson and Johnson  10.60 %
Tenet Healthcare Corp  10.49 %
Bristol myers Squibb Company  10.27 %
Solventum Corporation  10.13 %
Globus Medical Inc   10.04 %
Universal Health Services Inc   9.92 %
Entrada Therapeutics Inc   9.51 %
Amgen Inc   9.48 %
National Healthcare Corp  9.28 %
Tactile Systems Technology Inc   9.17 %
Bioventus Inc   9.08 %
Infusystem Holdings Inc  8.63 %
Penumbra Inc  8.63 %
Utah Medical Products Inc  8.50 %
Boston Scientific Corporation  8.34 %
3m Company  8.27 %
Jazz Pharmaceuticals Plc  8.19 %
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %

Date modified: 2026-09-26T07:05:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.